| A real-world perspective of CD123 expression in acute leukemia as promising biomarker to predict treatment outcome in B-ALL and AML N Das, R Gupta, SK Gupta, S Bakhshi, A Malhotra, S Rai, S Singh, ... Clinical Lymphoma Myeloma and Leukemia 20 (10), e673-e684, 2020 | 19 | 2020 |
| Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous?-A retrospective cohort study P Sirohiya, A Elavarasi, HKR Sagiraju, M Baruah, N Gupta, RK Garg, ... Lung India 39 (3), 247-253, 2022 | 16 | 2022 |
| Cell-free DNA for genomic profiling and minimal residual disease monitoring in Myeloma-are we there yet? D Thakral, N Das, A Basnal, R Gupta American Journal of Blood Research 10 (3), 26, 2020 | 13 | 2020 |
| The effectiveness of SARS-CoV-2 vaccination in preventing severe illness and death–real-world data from a cohort of patients hospitalized with COVID-19 HKR Sagiraju, A Elavarasi, N Gupta, RK Garg, SS Paul, S Vig, P Sirohiya, ... Indian Journal of Community Medicine 47 (4), 510-516, 2022 | 12 | 2022 |
| Relevance of polyclonal plasma cells and post‐therapy immunomodulation in measurable residual disease assessment in multiple myeloma N Das, M Dahiya, R Gupta, L Kumar, A Sharma, S Rai, S Singh, ... Cytometry Part B: Clinical Cytometry 102 (3), 209-219, 2022 | 12 | 2022 |
| Critical evaluation of the utility of pre-and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALL N Das, R Gupta, SK Gupta, S Bakhshi, R Seth, C Kumar, S Rai, S Singh, ... Annals of Hematology 100 (10), 2487-2500, 2021 | 10 | 2021 |
| Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognition N Das, M Dahiya, R Gupta, S Rai, S Singh, VK Prajapati, L Kumar, ... Cytometry Part B: Clinical Cytometry 102 (4), 292-302, 2022 | 9 | 2022 |
| Effect of the sequence of pull of bone marrow aspirates on plasma cell quantification in plasma cell proliferative disorders G Jain, N Das, S Gajendra, SP Gangwar, R Gupta, S Mallik, A Sharma, ... International Journal of Laboratory Hematology 44 (5), 837-845, 2022 | 5 | 2022 |
| FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small … N Das, D Thakral, G Singh, A Malhotra, RH Phulware, A Gogia, R Gupta Indian Journal of Pathology and Microbiology 62 (4), 614-617, 2019 | 4 | 2019 |
| Utility of CD229 as novel marker in measurable residual disease assessment in multiple myeloma—An evidence‐based approach S Rai, N Das, R Gupta, L Kumar, A Sharma, S Singh, VK Prajapati International Journal of Laboratory Hematology 45 (2), 179-186, 2023 | 2 | 2023 |
| Graded depth of response and neoplastic plasma cell index as indicators of survival outcomes in patients with multiple myeloma following autologous stem cell transplant N Das, M Dahiya, R Gupta, L Kumar, L Rani, A Gupta, A Farswan, ... American Journal of Clinical Pathology 159 (1), 69-80, 2023 | 2 | 2023 |
| Hematological Predictors of COVID-19 Severity T Dwivedi, R Gupta, N Das, A Raj, P Tiwari, S Vig, B Ratre, S Bhatnagar, ... Indian Journal of Hematology and Blood Transfusion, S120-S121, 2021 | 2 | 2021 |
| The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study From a Tertiary Care Hospital in India T Dwivedi, A Raj, N Das, R Gupta, N Gupta, P Tiwari, B Sahoo, ... Cureus 15 (6), 2023 | 1 | 2023 |
| Genomic landscape of mature B-cell non-Hodgkin lymphomas—an appraisal from lymphomagenesis to drug resistance D Panda, N Das, D Thakral, R Gupta Journal of the Egyptian National Cancer Institute 34 (1), 52, 2022 | 1 | 2022 |
| Analytical Appraisal of Hematogones in B-ALL MRD Assessment Using Multidimensional Dot-Plots by Multiparametric Flow Cytometry: A Critical Review and Update N Das, S Gajendra, R Gupta Indian Journal of Hematology and Blood Transfusion 40 (1), 12-24, 2024 | | 2024 |
| Persistence of SARS-CoV-2 Antibodies for a Year Following SARS-CoV-2 Vaccinations (BBV152 and ChAdOx1 nCoV-19) T Dwivedi, A Raj, N Das, R Gupta, S Bhatnagar, A Mohan, R Guleria Indian Journal of Clinical Biochemistry, 1-10, 2023 | | 2023 |
| Voyage of Measurable Residual Disease (MRD) Assessment in Multiple Myeloma Using Multiparametric Flow Cytometry N Das, R Gupta Indian Journal of Medical and Paediatric Oncology, 2023 | | 2023 |
| MM-267 Expression of CD229 on Bone Marrow Cellular Compartment and Its Relevance in Multiple Myeloma S Rai, R Gupta, N Das Clinical Lymphoma Myeloma and Leukemia 22, S417, 2022 | | 2022 |
| AML-230 Predictive Value of CD34-Positive versus CD34-Negative Leukemic Stem Cells on Survival Outcome in Acute Myeloid Leukemia N Das, D Panda, R Gupta, S Gajendra, S Bakhshi, A Sharma, RK Sahoo, ... Clinical Lymphoma Myeloma and Leukemia 22, S226-S227, 2022 | | 2022 |
| Poster: AML-230 Predictive Value of CD34-Positive versus CD34-Negative Leukemic Stem Cells on Survival Outcome in Acute Myeloid Leukemia N Das, D Panda, R Gupta, S Gajendra, S Bakhshi, A Sharma, RK Sahoo, ... Clinical Lymphoma, Myeloma and Leukemia 22, S131, 2022 | | 2022 |
Ritu GuptaProfessor, Laboratory Oncology Unit, Dr. B.R.A.IRCH, AIIMSVerified email at aiims.edu
